REPRO MED SYSTEMS INC
NASDAQ: KRMD (KORU Medical Systems, Inc.)
Last update: 9 hours ago4.02
0.32 (8.65%)
Previous Close | 3.70 |
Open | 3.65 |
Volume | 209,200 |
Avg. Volume (3M) | 56,112 |
Market Cap | 184,265,952 |
Price / Sales | 5.89 |
Price / Book | 10.65 |
52 Weeks Range | |
Earnings Date | 13 Nov 2024 |
Profit Margin | -38.16% |
Operating Margin (TTM) | -14.14% |
Diluted EPS (TTM) | -0.260 |
Quarterly Revenue Growth (YOY) | 21.50% |
Total Debt/Equity (MRQ) | 21.21% |
Current Ratio (MRQ) | 3.77 |
Levered Free Cash Flow (TTM) | 1.05 M |
Return on Assets (TTM) | -14.10% |
Return on Equity (TTM) | -50.25% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | KORU Medical Systems, Inc. | Bullish | Bullish |
AIStockmoo Score
Analyst Consensus | -1.5 |
Insider Activity | NA |
Price Volatility | -5.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 4.0 |
Average | -0.63 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Core |
% Held by Insiders | 6.30% |
% Held by Institutions | 54.38% |
Ownership
Name | Date | Shares Held |
---|---|---|
Albion Financial Group /Ut | 30 Sep 2024 | 667,783 |
272 Capital Lp | 30 Sep 2024 | 302,115 |
Archon Capital Management Llc | 30 Sep 2024 | 188,900 |
White Pine Capital Llc | 30 Sep 2024 | 125,741 |
Highmark Wealth Management Llc | 30 Sep 2024 | 120,935 |
52 Weeks Range | ||
Price Target Range | ||
High | 5.00 (Craig-Hallum, 24.38%) | Buy |
Median | 4.00 (-0.50%) | |
Low | 3.50 (Piper Sandler, -12.94%) | Buy |
Average | 4.17 (3.73%) | |
Total | 3 Buy | |
Avg. Price @ Call | 3.08 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Canaccord Genuity | 14 Nov 2024 | 4.00 (-0.50%) | Buy | 3.08 |
Craig-Hallum | 14 Nov 2024 | 5.00 (24.38%) | Buy | 3.08 |
Piper Sandler | 14 Nov 2024 | 3.50 (-12.94%) | Buy | 3.08 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |